Cargando…

Mutational Analysis of Circulating Tumor Cells from Colorectal Cancer Patients and Correlation with Primary Tumor Tissue

Circulating tumor cells (CTCs) provide a non-invasive accessible source of tumor material from patients with cancer. The cellular heterogeneity within CTC populations is of great clinical importance regarding the increasing number of adjuvant treatment options for patients with metastatic carcinomas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyberopoulou, Anna, Aravantinos, Gerasimos, Efstathopoulos, Efstathios P., Nikiteas, Nikolaos, Bouziotis, Penelope, Isaakidou, Athina, Papalois, Apostolos, Marinos, Evangelos, Gazouli, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406761/ https://www.ncbi.nlm.nih.gov/pubmed/25902072 http://dx.doi.org/10.1371/journal.pone.0123902

Ejemplares similares

Ag/Au Bimetallic Nanoparticles Inhibit Tumor Growth and Prevent Metastasis in a Mouse Model
por: Katifelis, Hector, et al.
Publicado: (2020)

The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance
por: Lampropoulou, Dimitra Ioanna, et al.
Publicado: (2022)

Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer
por: Pliakou, Evangelia, et al.
Publicado: (2022)

Oxidative and pre-inflammatory stress in wedge resection of pulmonary parenchyma using the radiofrequency ablation technique in a swine model
por: Karaiskos, Theodoros, et al.
Publicado: (2012)

Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2017)

Exosomal noncoding RNAs in cholangiocarcinoma: Laboratory noise or hope?
por: Laschos, Konstantinos, et al.
Publicado: (2020)

The Role of EMT-Related lncRNAs in Ovarian Cancer
por: Lampropoulou, Dimitra Ioanna, et al.
Publicado: (2023)

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
por: Negru, Serban, et al.
Publicado: (2014)

Advances in Colorectal Cancer
por: Nikiteas, Nikolaos I., et al.
Publicado: (2016)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Association between homeobox protein transcript antisense intergenic ribonucleic acid genetic polymorphisms and cholangiocarcinoma
por: Lampropoulou, Dimitra Ioanna, et al.
Publicado: (2021)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
por: Tzanikou, Eleni, et al.
Publicado: (2019)

Synchronous Gastric Adenocarcinoma and Diffuse Large B-Cell Lymphoma in the Pelvis: A Rare Case Presentation
por: Pliakou, Evangelia, et al.
Publicado: (2022)

(99m)Tc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2022)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Nanomedicine approaches for treatment of hematologic and oncologic malignancies
por: Nteli, Polyxeni, et al.
Publicado: (2022)

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review
por: Aravantinos, Gerasimos, et al.
Publicado: (2014)

Exercise-Induced Changes in Tumor Growth via Tumor Immunity
por: Spiliopoulou, Polyxeni, et al.
Publicado: (2021)

Meta-analysis of the mutational status of circulation tumor cells and paired primary tumor tissues from colorectal cancer patients
por: Liu, Yong, et al.
Publicado: (2017)

Comparison of cosmetic outcomes between remote‐access and conventional thyroidectomy: A review of the current literature
por: Kasouli, Anna, et al.
Publicado: (2022)

Analysis of colorectal cancer‐related mutations by liquid biopsy: Utility of circulating cell‐free DNA and circulating tumor cells
por: Takeda, Kohki, et al.
Publicado: (2019)

Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status
por: Lessi, Francesca, et al.
Publicado: (2023)

KRAS mutation analysis of single circulating tumor cells from patients with metastatic colorectal cancer
por: Kondo, Yuurin, et al.
Publicado: (2017)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Breath Analysis: A Promising Tool for Disease Diagnosis—The Role of Sensors
por: Kaloumenou, Maria, et al.
Publicado: (2022)

Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma
por: Ge, Zhouhong, et al.
Publicado: (2021)

Early mutation bursts in colorectal tumors
por: Zhao, Junsong, et al.
Publicado: (2017)

Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel
por: Sato, Kei A., et al.
Publicado: (2016)

KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients
por: GUTIÉRREZ, CRISTINA, et al.
Publicado: (2013)

Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer
por: Nakamura, Yuki, et al.
Publicado: (2021)

Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue
por: Markou, Athina N.
Publicado: (2020)

Emerging therapies in thymic epithelial tumors (Review)
por: Dapergola, Athina, et al.
Publicado: (2023)

The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor
por: Wang, Qi, et al.
Publicado: (2019)

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer
por: Fountzilas, Elena, et al.
Publicado: (2018)

Coexistence of gastrointestinal stromal tumor (GIST) and colorectal adenocarcinoma: A case report
por: Efstathios, Papalambros, et al.
Publicado: (2007)

Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer
por: Vafaei, Somayeh, et al.
Publicado: (2020)

Using the polymeric circulating tumor cell chip to capture circulating tumor cells in blood samples of patients with colorectal cancer
por: Kure, Kazumasa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7kipb203vu4oal7q778645ngtt